Last edition
News about "Swedish Orphan Biovitrum,"
Innate Pharma Partners with Sobi to License Lacutamab in T-cell Lymphoma
Innate Pharma and Sobi have partnered to advance lacutamab in T-cell lymphoma, with Innate leading the TELLOMAK-3 phase 3 trial in CTCL.
Swedish Orphan Biovitrum, | 11/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members